GE Healthcare has formed a manufacturing agreement with Advanced Accelerator Applications, a pharmaceutical company based in Milan, Italy, and focused on molecular nuclear medicine.

In collaboration with four French partners, health IT research company CEA-Leti has launched a project to develop a PET tracer incorporating the company’s patented Lipidot nano-carrier, which would function for both pre-operative nuclear imaging and intraoperative optical imaging of cancers.